Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs

被引:100
|
作者
Pasquereau, Sebastien [1 ]
Kumar, Amit [1 ]
Herbein, Georges [1 ]
机构
[1] Univ Franche Comte, Dept Virol, Univ Bourgogne Franche Comte UBFC,CHRU Besancon, UPRES Pathogens & Inflammat EA4266,EPILAB,SFR FED, F-25030 Besancon, France
来源
VIRUSES-BASEL | 2017年 / 9卷 / 04期
关键词
TNF; TNF receptor; HIV-1; reservoirs; immune activation; anti-TNF therapy; TUMOR-NECROSIS-FACTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; NF-KAPPA-B; CD4(+) T-CELLS; PRIMARY HUMAN MACROPHAGES; PERIPHERAL-BLOOD MONOCYTES; REACTIVATES LATENT HIV-1; FACTOR-ALPHA; SIGNAL-TRANSDUCTION; TERMINAL KINASE;
D O I
10.3390/v9040064
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Several cellular functions such as apoptosis, cellular proliferation, inflammation, and immune regulation involve the tumor necrosis factor-alpha (TNF)/TNF receptor (TNFR) pathway. Human immunodeficiency virus 1 (HIV-1) interacts with the TNF/TNFR pathway. The activation of the TNF/TNFR pathway impacts HIV-1 replication, and the TNF/TNFR pathway is the target of HIV-1 proteins. A hallmark of HIV-1 infection is immune activation and inflammation with increased levels of TNF in the plasma and the tissues. Therefore, the control of the TNF/TNFR pathway by new therapeutic approaches could participate in the control of immune activation and impact both viral replication and viral persistence. In this review, we will describe the intricate interplay between HIV-1 proteins and TNF/TNFR signaling and how TNF/TNFR activation modulates HIV-1 replication and discuss new therapeutic approaches, especially anti-TNF therapy, that could control this pathway and ultimately favor the clearance of infected cells to cure HIV-infected patients.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Targeting Astrocyte HIV-1 Proviral Reservoirs in HAND
    Edara, Venkata Viswanadh
    Ghorpade, Anuja
    JOURNAL OF NEUROVIROLOGY, 2018, 24 : S25 - S25
  • [42] The Many Faces of Immune Activation in HIV-1 Infection: A Multifactorial Interconnection
    Mazzuti, Laura
    Turriziani, Ombretta
    Mezzaroma, Ivano
    BIOMEDICINES, 2023, 11 (01)
  • [43] Persistent immune activation in HIV-1 infection is associated with progression to AIDS
    Hazenberg, MD
    Otto, SA
    van Benthem, BHB
    Roos, MTL
    Coutinho, RA
    Lange, JMA
    Hamann, D
    Prins, M
    Miedema, F
    AIDS, 2003, 17 (13) : 1881 - 1888
  • [44] WEIGHT-LOSS IN HIV-1 INFECTION IS ASSOCIATED WITH IMMUNE ACTIVATION
    ZANGERLE, R
    REIBNEGGER, G
    WACHTER, H
    FUCHS, D
    AIDS, 1993, 7 (02) : 175 - 181
  • [45] Is HIV infection a TNF receptor signalling-driven disease?
    Herbein, Georges
    Khan, Kashif Aziz
    TRENDS IN IMMUNOLOGY, 2008, 29 (02) : 61 - 67
  • [46] The macrophage in HIV-1 infection: From activation to deactivation?
    Herbein, Georges
    Varin, Audrey
    RETROVIROLOGY, 2010, 7
  • [47] The macrophage in HIV-1 infection: From activation to deactivation?
    Georges Herbein
    Audrey Varin
    Retrovirology, 7
  • [48] Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
    Pierson, T
    McArthur, T
    Siliciano, RF
    ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 665 - 708
  • [49] HIV-1 Tat Induces Neuronal Insulin Receptor Secretion Through the TNF-Alpha Receptor
    Gerena, Yamil
    Menindez-Delmestre, Raissa
    Delgado-Nieves, Andrea
    Gonziclez-Escalante, Anibal
    Colin-Cruz, Luis
    Marshall-Freites, Valerie
    Rivera-Morales, Paola
    Nath, Avindra
    Wojna, Valerie
    JOURNAL OF NEUROVIROLOGY, 2016, 22 : S22 - S22
  • [50] Designed antiviral ankyrin - A computational approach to combat HIV-1 via intracellular pathway by targeting the viral capsid of HIV-1
    Karim, Hana Atiqah Abdul
    Rungrotmongkol, Thanyada
    Zain, Sharifuddin M.
    Abd Rahman, Noorsaadah
    Tayapiwattana, Chatchai
    Lee, VannajanSanghiran
    JOURNAL OF MOLECULAR LIQUIDS, 2019, 277 : 63 - 69